SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148305

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148305

Global and U.S. Veterinary Drugs Market, By Drug Type, By Type, By Indication, By Animal Type, By Route of Administration, By Dosage Form, By Distribution Channel, By Geography

PUBLISHED:
PAGES: 257 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Global and U.S. Veterinary Drugs Market is estimated to be valued at USD 24,905.8 Mn in 2026 and is expected to reach USD 48,197.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 24,905.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.90% 2033 Value Projection: USD 48,197.5 Mn

The global and U.S. veterinary drugs market is a significant segment comprising pharmaceuticals such as antibiotics, antiparasitic, anti-inflammatories, and analgesics used to prevent and treat diseases in companion animals, livestock, and aquatic species. The demand for veterinary pharmaceuticals is being driven globally by the increasing pet humanization, growing demand for animal-derived protein, increasing prevalence of zoonotic diseases, and growing focus on animal welfare.

In the U.S., the safety, efficacy and quality of veterinary drugs is ensured by a robust regulatory system led by the U.S. FDA's Center for Veterinary Medicine (FDA-CVM). On the global scale, growing livestock production, urbanization and heightened awareness of animal health are creating new opportunities for growth, while antimicrobial resistance is spurring innovation in drug development and responsible use.

Market Dynamics

The global and U.S. veterinary drugs market is driven by the rising pet population, increasing animal protein consumption, and rising demand for systematic livestock healthcare. Advancements in veterinary pharmaceuticals such as biologics, specialized therapies, and innovative drug-delivery systems, are creating extra treatment options, and the improvement of veterinary healthcare infrastructure in emerging economies is widening access to animal medicines.

However, the growth of organic capsules market is limited by factors such as stringent regulatory requirements, increasing concerns related to antimicrobial resistance and high veterinary treatment costs. Nevertheless, the growing trend toward preventive animal healthcare, development of digital veterinary services, increasing aquaculture health management and demand for antibiotic-free animal products are creating significant opportunities for innovative vaccines, long-acting therapies and precision-based veterinary treatments.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global and U.S. veterinary drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis Inc., Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Incorporated, Virbac S.A., Ceva Sante Animale S.A., Dechra Pharmaceuticals Limited, Vetoquinol S.A., Phibro Animal Health Corporation, and Norbrook Laboratories Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global and U.S. veterinary drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global and U.S. veterinary drugs market

Market Segmentation

  • Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Antibiotics
    • Nonsteroidal Anti-inflammatory Drug
    • Antiparasitic Drugs
    • Antihistamines
    • Antiemetic Drugs
    • Anti-ulcer Agents
    • Diuretics
    • Anaesthetic Agents
    • Anticancer Agents
    • Hormonal and Hormone Replacement Agents
    • Others
  • Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Branded
    • Generics
  • Indication Insights (Revenue, USD Mn, 2021 - 2033)
    • Digestive System Disease
    • Immunologic Disease
    • Nervous System Disease
    • Reproductive System Disease
    • Respiratory System Disease
    • Dermatological Disease
    • Oncology
    • Hormonal Disorder
    • Cardiovascular Disease
    • Others
  • Animal Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Companion Animal
    • Livestock
  • Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
    • Oral
    • Parenteral
    • Topical
  • Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
    • Tablets and Capsules
    • Suspensions and Emulsions
    • Powders and Pastes
    • Gels, Creams and Ointments
    • Sprays
    • Others
  • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
    • Veterinary Hospitals
    • Veterinary Clinics
    • Retail Pharmacies
    • Online Pharmacies
    • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Zoetis Inc.
    • Boehringer Ingelheim International GmbH
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Virbac S.A.
    • Ceva Sante Animale S.A.
    • Dechra Pharmaceuticals Limited
    • Vetoquinol S.A.
    • Phibro Animal Health Corporation
    • Norbrook Laboratories Limited
Product Code: CMI10028

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global and U.S. Veterinary Drugs Market, By Drug Type
    • Global and U.S. Veterinary Drugs Market, By Type
    • Global and U.S. Veterinary Drugs Market, By Indication
    • Global and U.S. Veterinary Drugs Market, By Animal Type
    • Global and U.S. Veterinary Drugs Market, By Route of Administration
    • Global and U.S. Veterinary Drugs Market, By Dosage Form
    • Global and U.S. Veterinary Drugs Market, By Distribution Channel
    • Global and U.S. Veterinary Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global and U.S. Veterinary Drugs Market, By Drug Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Nonsteroidal Anti-inflammatory Drug
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Antiparasitic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Antihistamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Antiemetic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Anti-ulcer Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Diuretics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Anaesthetic Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Anticancer Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hormonal and Hormone Replacement Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global and U.S. Veterinary Drugs Market, By Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Generics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global and U.S. Veterinary Drugs Market, By Indication, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Digestive System Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Immunologic Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Nervous System Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Reproductive System Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Respiratory System Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Dermatological Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hormonal Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Cardiovascular Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global and U.S. Veterinary Drugs Market, By Animal Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Companion Animal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Livestock
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global and U.S. Veterinary Drugs Market, By Route of Administration, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global and U.S. Veterinary Drugs Market, By Dosage Form, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Tablets and Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Suspensions and Emulsions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Powders and Pastes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Gels, Creams and Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

10. Global and U.S. Veterinary Drugs Market, By Distribution Channel, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Veterinary Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Veterinary Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

11. Global and U.S. Veterinary Drugs Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

12. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco Animal Health Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ceva Sante Animale S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phibro Animal Health Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Norbrook Laboratories Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

13. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

14. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!